Back to Agenda
Strategic Planning Across Research Organizations
Session Chair(s)
Shurjeel Choudhri
Senior Vice President and Head, Medical and Scientific Affairs, Bayer, Canada
Leveraging innovative technologies, cutting edge research, and unique capabilities are the hallmarks of robust drug discovery and development. Government organizations approach these activities differently and regional variation can also play a role in how research is conducted. Understanding these perspectives can lead to more effective collaborations. This session will give the audience insights on strategic planning and implementation of partnerships using examples from Canada, the US and the Pharma industry.
Learning Objective : Discuss how clinical research is conducted in Canada; Identify key differences that can be leveraged in executing effective collaborations.
Speaker(s)
Initiatives for Enhancing the Canadian Clinical Research Environment: A Showcase of Cross-Sectoral Collaborations
Senior Vice President and Head, Medical and Scientific Affairs, Bayer, Canada
Innovative Approaches to Getting Products to Market: The Experience in an Academic Medical Center
Director, Clinical Research & Early Product Dev., Center for Cell & Gene Therapy, Baylor College of Medicine, United States
Industry Perspective for Strategic Collaboration
Chief Executive Officer , TransCelerate Biopharma Inc., United States
Have an account?